patients with advanced stage follicular lymphoma who received rituximab in combination with chemotherapy were significantly less likely to experience treatment failure than patients who received ...

A panelist discusses how, despite recent advances in relapsed/refractory follicular lymphoma treatment, important unmet needs ...

Looking for reliable medications to treat 'Follicular Lymphoma'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

Even if care teams have all of your information on their end, advocating for yourself is still necessary during cancer treatment. Recently, I met a fellow cancer survivor but after talking with her ...

And there are also potentially plans to bring the drug to frontline treatment of follicular lymphoma. So, in terms of sequencing, I think we'll have to see what's going to happen with the CD20 T ...

Follicular lymphoma treatment responses vary significantly, with some patients achieving NED while others require multiple treatment lines. The author experiences survivor's guilt, questioning why ...

For the follicular lymphoma trial, Alderuccio and his colleagues enrolled patients whose cancer had not only relapsed or failed to respond to treatment but also showed a high disease burden or had ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

Roche has secured its first regulatory approval for mosunetuzumab, a first-in-class CD20xCD3 bispecific antibody, as a treatment for patients with follicular lymphoma (FL) in the EU.

Dark zone lymphoma includes aggressive B-cell lymphomas with shared molecular features. While some respond to escalated ...

Cancer-related fear and fatalism are more prevalent in patients of racial minority groups with indolent blood cancer, ...